Rare diseases remain a formidable public health challenge. The key to unlocking breakthroughs in diagnosis and treatment is fostering dynamic international partnerships and streamlined data sharing. The empowerment of patient advocacy groups is essential, as they are pivotal in driving innovative research and elevating health-care standards for these often under-represented conditions.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 1 digital issues and online access to articles
$99.00 per year
only $99.00 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Wakap, S. N. et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur. J. Hum. Genet. 28, 165–173 (2020).
Dye, D. E., Brameld, K. J., Maxwell, S., Goldblatt, J. & O’Leary, P. The impact of single gene and chromosomal disorders on hospital admissions in an adult population. J. Community Genet. 2, 81–90 (2011).
Rose, A. M. et al. The financial and time burden associated with phenylketonuria treatment in the United States. Mol. Genet. Metab. Rep. 21, 100523 (2019).
Gahl, W. A. et al. The NIH Undiagnosed Diseases Program: insights into rare diseases. Genet. Med. 14, 51–59 (2012).
Ramoni, R. B. et al. The Undiagnosed Diseases Network: accelerating discovery about health and disease. Am. J. Hum. Genet. 100, 185–192 (2017).
Sciascia, S. et al. Unmet needs in countries participating in the undiagnosed diseases network international: an international survey considering national health care and economic indicators. Front. Public. Health. 11, 1248260 (2023).
Gahl, W. A., Thoene, J. G. & Schneider, J. A. Cystinosis. N. Engl. J. Med. 347, 111–121 (2002).
Benito-Lozano, J., López-Villalba, B., Arias-Merino, G., Posada de la Paz, M. & Alonso-Ferreira, V. Diagnostic delay in rare diseases: data from the Spanish rare diseases patient registry. Orphanet J. Rare Dis. 17, 418 (2022).
Taruscio, D. & Mantovani, A. Multifactorial rare diseases: can uncertainty analysis bring added value to the search for risk factors and etiopathogenesis? Medicina 2, 119 (2021).
Huizing, M. et al. Free sialic acid storage disease: progress and promise. NeuroSci. Lett. 755, 135896 (2021).
Acknowledgements
D.T. was the Director of the National Center for Rare Diseases, Istituto Superiore di Sanità (Rome, Italy) until 31 August 2022 and most activities on rare diseases were performed in this institutional role. Both authors are board members of the Undiagnosed Diseases Network International (UDNI) and they are grateful to all other UDNI members.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Taruscio, D., Gahl, W.A. Rare diseases: challenges and opportunities for research and public health. Nat Rev Dis Primers 10, 13 (2024). https://doi.org/10.1038/s41572-024-00505-1
Published:
DOI: https://doi.org/10.1038/s41572-024-00505-1
